Effect of plasma from patients with idiopathic nephrotic syndrome on proteoglycan synthesis by human and rat glomerular cells

Pediatric Research

Volumn 43, Issue 4 I, 1998, Pages 489-495

  Girardin, Eric P ^a   Birmele, Beatrice ^a   Benador, Nadine ^a   Neuhaus, Thomas ^b   Hosseini, Ghamartaj ^a   Van Den Heuvel, Lambertus P W J ^c   De Agostini, Ariane ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PROTEOGLYCAN;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULUS EPITHELIUM; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; NEPHROTIC SYNDROME; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; RAT; RELAPSE; REMISSION;

EID: 0031953776     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199804000-00009     Document Type: Article

References (49)

1. Habib R 1973 Editorial: focal glomerular sclerosis. Kidney Int 4:355-361
2. Churg J, Habib R, White R 1970 Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299-1302
3. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael A 1972 Recurrence of idiopathic nephrotic syndrome after renall transplantation. Lancet 2:343-348
4. Lagrue G, Branellec A, Niaudet P, Heslan JM, Guillot F, Lang P 1991 Transmission d'un syndrome néphrotique à deux nouveau-nés. Régressionn spontanée. (Transmission of nephrotic syndrome to two neonates. Spontaneouss regression). Presse Med 20:255-257
5. Shalhoub R 1974 Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556-560
6. Schnaper HW, Pierce CW, Aune T 1984 Identification and initial characterization of concanavalin A-and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS). J Immunol 132:2429-2435
7. Heslan JM, Branellec AI, Pilatte Y, Lang P, Lagrue G 1991 Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome. Clin Exp Immunol 86:157-162
8. Tanaka R, Yoshikawa N, Nakamura H, Ito H 1992 Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats Nephron 60:35-41
9. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Deligny BH, Niaudet P, Charpentier B, Soulillou JP 1994 Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14
10. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swann SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F 1996 Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883
11. Groggel GC, Stevenson J, Hovingh P, Linker A, Border WA 1988 Changes in heparan sulfate correlate with increased glomerular permeability. Kidney Int 33:517-523
12. Myers BD, Guasch A 1994 Mechanisms of proteinuria in nephrotic humans. Pediatr J Nephrol 8:107-112
13. Comper WD, Glasgow EF 1995 Charge selectivity in kidney ultrafiltration. Kidney Int 47:1242-1251
14. Kato M, Koike Y, Suzuki S, Kimata K 1988 Basement membrane proteoglycan in various tissues: characterization using monoclonal antibodies to the Engelbreth-Holm-Swarm mouse tumor low density heparan sulfate proteoglycan. J Cell Biol 106:2203-2210
15. Soroka CJ, Farquhar M 1991 Characterization of a novel heparan sulfate proteoglycan found in the extracellular matrix of liver sinusoids and basement membranes. J Cell J Biol 113:1231-1241
16. Aumailley M 1995 Structure and supramolecular organization of basement membranes. Kidney Int 47:S4-S7
17. Thomas GJ, Shewring L, McCarthy KJ, Couchman JR, Mason RM, Davies M 1995 Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. Kidney Int 48:1278-1289
18. Levin M, Smith C, Walters MD, Gascoine P, Barratt TM 1985 Steroid-responsive nephrotic syndrome: a generalised disorder of membrane negative charge. Lancet 2:239-242
19. Quatacker J, Praet M, Matthys E 1987 Ultrastructural alterations in the sialic acid distribution in minimal change disease and membranous glomerulonephritis. Pathol Res Pract 182:188-194
20. Kitano Y, Yoshikawa N, Nakamura H 1993 Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Clin Nephrol 40:199-204
21. Ueda Y, Ono Y, Sagiya A, Kanaya H, Iidaka K 1992 Mesangial anionic sites are decreased in human focal glomerular sclerosis. Clin Nephrol 37:280-284
22. Van Den Born J, Van Den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Weening JJ, Berden JHM 1993 Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 43:454-463
23. International Study of Kidney Disease in Children 1981 The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561-564
24. Ruef C, Budde K, Lacy J, Northemann W, Baumann M, Sterzel RB, Coleman D 1990 Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int 38:249-257
25. Harper PA, Robinson JM, Hoover RL, Wright TC, Karnovsky MJ, 1984 Improved methods for culturing rat glomerular cells. Kidney Int 26:875-880
26. Striker GE, Killen PD, Farin FM 1980 Human glomerular cells in vitro: isolation and characterization. Transplant Proc 12:88-100
27. Striker GE, Striker LJ 1980 Biology of Disease, glomerular cell culture. Lab Invest 53:122-131
28. Ardaillou R 1996 Biology of glomerular cells in culture. Cell Biol Toxicol 12:257-261
29. Rapraeger A, Yeaman C 1989 A quantitative solid-phase assay for identifying radiolabeled glycosaminoglycans in crude cell extracts. Anal Biochem 179:361-365
30. Lindahl U, Backstrom G, Jansson L, Hallen A 1973 Biosynthesis of Heparin. II. Formation of sulfamino groups. J Biol Chem 248:7234-7241
31. Shworak NW, Shirakawa M, Colliec-Jouault S, Liu J, Mulligan RC, Biriny LK, Rosenberg RD 1996 Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate. J Biol Chem 269:24941-24952
32. Bradford MM 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
33. 2 synthesis. Microvase Res 50:154-161
34. Campbell MJ, Gardner MJ 1989 Statistics with confidence. BMJ 71-76
35. Garin EH, Boggs KP 1985 Effect of supernatants from nephrotic peripheral blood mononuclear cells on sulfate-35 incorporation in rat glomerular basement membrane. Pediatr Res 19:836-840
36. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M 1991 A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453-460
37. Adal Y, Smit MF, Osicka TM, Comper WD 1995 Albumin interaction with the glomerular capillary wall in vitro. Kidney Int 47:1031-1038
38. Gambaro G, Cavazzana AO, Luzi P, Piccoli A, Borsatti A, Crepaldi G, Marchi E, Venturini AP, Baggio B 1992 Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42:285-291
39. Kitano Y, Yoshikawa N, Nakamura H 1993 Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Clin Nephrol 40:199-204
40. Washizawa K, Kasai S, Mori T, Komiyama A, Shigematsu H 1993 Ultrastructural alteration of glomerular anionic sites in nephrotic patients. Pediatr Nephrol 7:1-5
41. Ramjee G, Coovadia HM, Adhikari M 1996 Direct and indirect tests of pore size and charge selectivity in nephrotic syndrome. J Lab Clin Med 127:195-199
42. Makino H, Gibbons JT, Kumudavalli Reddy M, Kanwar YS 1986 Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane-I. J Clin Invest 77:142-156
43. Miettinen A, Stow JL, Mentone S, Farquhar MG 1986 Antibodies to basement membrane heparan sulfate proteoglycans bind to the lamina rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 163:1064-1084
44. Van Den Born J, Van Den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM 1992 A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41:115-123
45. Salant DJ 1994 The structural biology of glomerular epithelial cells in proteinuric diseases. Curr Opin Nephrol Hypertens 3:569-574
46. Gelberg H, Healy L, Whiteley H, Miller LA, Vimr E 1996 In vivo enzymatic removal of α2→6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. Lab Invest 74:907-920
47. Pacifici R, Carano A, Santoro SA, Rifas L, Jeffrey JJ, Malone JD, McCracken R, Avioli LV 1991 Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest 87:221-228
48. 2-chloride system. Am J Pathol 143:907-917
49. Castillo GM, Templeton DM 1992 Structure and metabolism of multiple heparan sulphate proteoglycans synthesized by the isolated rat glomerulus. Biochim Biophys Acta 1136:119-128